The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016–2018: The Ohio Population-Based ALS Registry

Key points

This purpose of this publication was to report the incidence of ALS in Ohio residents diagnosed from October 2016 through September 2018.

Screenshot of first two pages of paper

Affiliates

Angeline S. Andrew [1], Erik P. Pioro [2], Meifang Li [3], Xun Shi [3], Jiang Gui [4], Elijah W. Stommel [1], Tanya H. Butt [1], Daniel Peipert [1],Patricia Henegan [1], Maeve Tischbein [1], Pamela Cazzolli [5] John Novak [6], Adam Quick [7], K. Doug Pugar [8], Komal Sawlani [9], Bashar Katirji [9], Todd A. Hayes [10], D. Kevin Horton [11], Paul Mehta [11], Walter G. Bradley [12]

  1. Department of Neurology, Geisel School of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA;
  2. Section of ALS and Related Disorders, Cleveland Clinic
  3. Department of Geography, Dartmouth College
  4. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth
  5. ALS Care Project
  6. Ohio Health Physician Group
  7. Department of Neurology, Ohio State University Wexner Medical Center
  8. Dayton Center for Neurological Disorders
  9. Department of Neurology, University Hospital Cleveland Medical Center
  10. Riverhills Neuroscience
  11. Centers for Disease Control and Prevention (CDC), Agency for Toxic Substances and Disease Registry (ATSDR)
  12. Department of Neurology, Miller School of Medicine, University of Miami

Journal

Neuroepidemiology

Summary

This study reports the incidence of ALS in Ohio residents diagnosed from October 2016 through September 2018. The Ohio estimated ALS incidence rates were comparable to other state reports in the US; however, there was geospatial variation of incidence estimates that require future investigation.

Link to Paper

Find the paper here!

Print
Content Source:
Agency for Toxic Substances and Disease Registry